UNITEDHEALTH GROUP INC Debt Disclosure
| Carrying Value as of December 31, | Carrying Value as of December 31, | |||||||||||||||||||||||||||||||
| (in millions, except percentages) | 2025 | 2024 | (continued) | 2025 | 2024 | |||||||||||||||||||||||||||
| Commercial paper | $ | 2,249 | $ | 1,300 | $850 5.8%, Mar 2036 | 839 | 838 | |||||||||||||||||||||||||
$2,000 3.75%, Jul 2025 | — | 1,999 | $500 6.5%, Jun 2037 | 492 | 492 | |||||||||||||||||||||||||||
$750 5.15% Oct 2025 | — | 749 | $650 6.625%, Nov 2037 | 641 | 641 | |||||||||||||||||||||||||||
$300 3.7%, Dec 2025 | — | 300 | $1,100 6.875%, Feb 2038 | 1,080 | 1,079 | |||||||||||||||||||||||||||
$500 1.25%, Jan 2026 | 500 | 499 | $1,250 3.5%, Aug 2039 | 1,243 | 1,243 | |||||||||||||||||||||||||||
$1,000 3.1%, Mar 2026 | 1,000 | 999 | $1,000 2.75%, May 2040 | 972 | 970 | |||||||||||||||||||||||||||
$1,000 1.15%, May 2026 | 989 | 953 | $300 5.7%, Oct 2040 | 297 | 296 | |||||||||||||||||||||||||||
$650 4.75%, Jul 2026 | 649 | 648 | $350 5.95%, Feb 2041 | 346 | 346 | |||||||||||||||||||||||||||
$500 floating rate, Jul 2026 | 500 | 499 | $1,500 3.05%, May 2041 | 1,485 | 1,485 | |||||||||||||||||||||||||||
$750 3.45%, Jan 2027 | 749 | 749 | $600 4.625%, Nov 2041 | 591 | 590 | |||||||||||||||||||||||||||
$500 4.6%, Apr 2027 | 498 | 496 | $502 4.375%, Mar 2042 | 487 | 487 | |||||||||||||||||||||||||||
$625 3.375%, Apr 2027 | 624 | 623 | $625 3.95%, Oct 2042 | 611 | 610 | |||||||||||||||||||||||||||
$600 3.7%, May 2027 | 599 | 598 | $750 4.25%, Mar 2043 | 737 | 737 | |||||||||||||||||||||||||||
$950 2.95%, Oct 2027 | 947 | 946 | $1,500 5.5%, Jul 2044 | 1,476 | 1,475 | |||||||||||||||||||||||||||
$1,000 5.25%, Feb 2028 | 1,010 | 998 | $2,000 4.75%, Jul 2045 | 1,977 | 1,976 | |||||||||||||||||||||||||||
$1,150 3.85%, Jun 2028 | 1,148 | 1,147 | $750 4.2%, Jan 2047 | 740 | 739 | |||||||||||||||||||||||||||
$500 4.40% Jun 2028 | 498 | — | $725 4.25%, Apr 2047 | 718 | 718 | |||||||||||||||||||||||||||
$850 3.875%, Dec 2028 | 847 | 847 | $950 3.75%, Oct 2047 | 936 | 935 | |||||||||||||||||||||||||||
$1,250 4.25%, Jan 2029 | 1,250 | 1,221 | $1,350 4.25%, Jun 2048 | 1,332 | 1,332 | |||||||||||||||||||||||||||
$400 4.7%, Apr 2029 | 406 | 398 | $1,100 4.45%, Dec 2048 | 1,088 | 1,087 | |||||||||||||||||||||||||||
$900 4%, May 2029 | 882 | 854 | $1,250 3.7%, Aug 2049 | 1,237 | 1,237 | |||||||||||||||||||||||||||
$1,000 2.875%, Aug 2029 | 943 | 902 | $1,250 2.9%, May 2050 | 1,213 | 1,212 | |||||||||||||||||||||||||||
$1,250 4.8%, Jan 2030 | 1,257 | 1,225 | $2,000 3.25%, May 2051 | 1,973 | 1,972 | |||||||||||||||||||||||||||
$1,250 5.3%, Feb 2030 | 1,272 | 1,243 | $2,000 4.75%, May 2052 | 1,967 | 1,966 | |||||||||||||||||||||||||||
$1,250 2%, May 2030 | 1,242 | 1,240 | $2,000 5.875%, Feb 2053 | 1,968 | 1,968 | |||||||||||||||||||||||||||
$750 4.65% Jan 2031 | 745 | — | $2,000 5.05%, Apr 2053 | 1,970 | 1,969 | |||||||||||||||||||||||||||
$1,000 4.9%, Apr 2031 | 1,010 | 982 | $1,750 5.375%, Apr 2054 | 1,730 | 1,729 | |||||||||||||||||||||||||||
$1,500 2.3%, May 2031 | 1,340 | 1,271 | $2,750 5.625%, Jul 2054 | 2,724 | 2,724 | |||||||||||||||||||||||||||
$1,500 4.95%, Jan 2032 | 1,490 | 1,489 | $750 5.95%, June 2055 | 735 | — | |||||||||||||||||||||||||||
$1,500 4.2%, May 2032 | 1,428 | 1,372 | $1,250 3.875%, Aug 2059 | 1,229 | 1,229 | |||||||||||||||||||||||||||
$2,000 5.35%, Feb 2033 | 2,024 | 1,966 | $1,000 3.125%, May 2060 | 967 | 967 | |||||||||||||||||||||||||||
$1,500 4.5%, Apr 2033 | 1,460 | 1,410 | $1,000 4.95%, May 2062 | 982 | 981 | |||||||||||||||||||||||||||
$1,250 5%, Apr 2034 | 1,250 | 1,214 | $1,500 6.05%, Feb 2063 | 1,466 | 1,466 | |||||||||||||||||||||||||||
$2,000 5.15%, Jul 2034 | 2,015 | 1,959 | $1,750 5.2%, Apr 2063 | 1,710 | 1,710 | |||||||||||||||||||||||||||
$1,000 5.3%, June 2035 | 992 | — | $1,100 5.5%, Apr 2064 | 1,086 | 1,085 | |||||||||||||||||||||||||||
$1,000 4.625%, Jul 2035 | 1,001 | 971 | $1,850 5.75%, Jul 2064 | 1,822 | 1,822 | |||||||||||||||||||||||||||
| Total short-term borrowings and long-term debt | $ | 77,681 | $ | 76,180 | ||||||||||||||||||||||||||||
| (in millions) | ||||||||
| 2026 | $ | 6,082 | ||||||
| 2027 | 3,530 | |||||||
| 2028 | 3,605 | |||||||
| 2029 | 3,655 | |||||||
| 2030 | 3,855 | |||||||
| Thereafter | 58,657 | |||||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 2, 2026 | Showing above |
| 2024 | Feb 27, 2025 | |
| 2023 | Feb 28, 2024 | |
| 2022 | Feb 24, 2023 | |
| 2021 | Feb 15, 2022 | |
| 2020 | Mar 1, 2021 | |
| 2019 | Feb 14, 2020 | |
| 2018 | Feb 12, 2019 | |
| 2017 | Feb 13, 2018 | |
| 2016 | Feb 8, 2017 | |
| 2015 | Feb 9, 2016 | |
About Debt Disclosures
Debt disclosures detail a company's borrowing structure — the types of instruments, interest rates, maturity schedule, and covenant restrictions that define its financial obligations and flexibility. This section is essential for assessing refinancing risk, interest rate exposure, and the margin of safety against financial distress.
Key signals: the maturity schedule reveals concentration risk — large maturities within 1-2 years during tight credit markets can force dilutive refinancing or asset sales. Compare the fair value of debt against carrying amount to gauge whether the market views the company's credit risk differently than the balance sheet suggests. Watch covenant compliance disclosures for tightening cushions, especially leverage and interest coverage ratios. Variable-rate debt exposure quantifies sensitivity to interest rate changes. Secured versus unsecured mix affects recovery rates and future borrowing capacity. Compare net debt-to-EBITDA against industry peers and covenant limits to assess financial health.